LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
LTH
Life Time Group Holdings, Inc.
LTH has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LTH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Weak | |
| Healthy |
LTH's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
LTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $41.05 | -9.9% |
| Current | 25x | $45.54 | — |
| Forward | 26x | $45.54 | — |
| Fair | 35x | $65.25 | +43% |
| Expensive | 46x | $85.57 | +88% |
Historical ranges are pointers, not guarantees.
LTH's PE is in its cheap range at 25x. On analysts' estimates for next year's earnings, today's price would be 26x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LTH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for LTH, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
LTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.76 | -4.6% |
| Q3 2026 | $1.85 | +45% |
| Q2 2026 | $1.84 | +80% |
| Q1 2026 | $1.71 | +78% |
| Q4 2025 | $1.66 | +124% |
| Q3 2025 | $1.28 | +88% |
| Q2 2025 | $1.02 | +92% |
| Q1 2025 | $0.96 | +174% |
| Q4 2024 | $0.74 | +100% |
LTH has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over LTH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
LTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $893.5M | +14% |
| Q2 2026 | $866M | +14% |
| Q1 2026 | $788.7M | +12% |
| Q4 2025 | $745.1M | +12% |
| Q3 2025 | $782.6M | +13% |
| Q2 2025 | $761.5M | +14% |
| Q1 2025 | $706M | +18% |
| Q4 2024 | $663.3M | +19% |
LTH's revenue has grown year over year for 22 quarters in a row: $894M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +0.4 points |
| Q2 2026 | 17% | +3 points |
| Q1 2026 | 17% | +1.9 points |
| Q4 2025 | 17% | +4.3 points |
| Q3 2025 | 17% | +3.8 points |
| Q2 2025 | 14% | -1.4 points |
| Q1 2025 | 15% | +3.2 points |
| Q4 2024 | 13% | +2.6 points |
LTH has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
LTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$26.6M | -193% |
| Q2 2026 | -$53.7M | -$27.4M |
| Q1 2026 | -$61.2M | -248% |
| Q4 2025 | -$64.6M | -341% |
| Q3 2025 | $28.6M | -55% |
| Q2 2025 | -$26.3M | -201% |
| Q1 2025 | $41.4M | +$107.8M |
| Q4 2024 | $26.8M | +$62.9M |
LTH has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
LTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +1.7M shares |
| 1 year | +1.3% | +3M shares |
| 3 years | +12% | +24.8M shares |
| 5 years | +58% | +83.9M shares |
| Available history | +58% | +84.1M shares |
LTH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $62.7M |
| Q1 2026 | $10.7M |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.8x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.4x | Moderate |
LTH's net debt is about 1.3 years of its operating earnings (EBITDA), down from 1.8 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
LTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.6 | Neutral |
| Stochastic | 80.6 | Overbought |
LTH's weekly RSI is 66 (neutral) and its Stochastic is 81 (overbought).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
LTH PE vs Consumer Cyclical Sector
| Metric | LTH | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 18x | 37% above |
| PE % | 28 | 56 | 28 pts below |
LTH is trading at 25x earnings, a 37% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
LTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.7 | 6.6% above |
| 20 week MA | $42.9 | 6.3% above |
| 50 week MA | $34.7 | 31% above |
| 100 week MA | $31.5 | 45% above |
| 200 week MA | $24.8 | 84% above |
LTH has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
LTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $17.2 | $18.1 | +5.1% |
| 2022 | $18.1 | $12.1 | -33% |
| 2023 | $12.1 | $15.1 | +24% |
| 2024 | $15.1 | $21.9 | +45% |
| 2025 | $21.9 | $26.8 | +22% |
| 2026 YTD | $26.8 | $45.5 | +70% |
LTH has the edge over LCID on returns for 2026, with the stronger performance.